These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37598025)

  • 41. Multilevel Determinants of COVID-19 Vaccine Uptake Among South Asian Ethnic Minorities in Hong Kong: Cross-sectional Web-Based Survey.
    Singh A; Lai AHY; Wang J; Asim S; Chan PS; Wang Z; Yeoh EK
    JMIR Public Health Surveill; 2021 Nov; 7(11):e31707. PubMed ID: 34653014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Covid-19 vaccination during the third trimester of pregnancy: rate of vaccination and maternal and neonatal outcomes, a multicentre retrospective cohort study.
    Rottenstreich M; Sela HY; Rotem R; Kadish E; Wiener-Well Y; Grisaru-Granovsky S
    BJOG; 2022 Jan; 129(2):248-255. PubMed ID: 34554630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determinants and Trends of COVID-19 Vaccine Hesitancy and Vaccine Uptake in a National Cohort of US Adults: A Longitudinal Study.
    Rane MS; Kochhar S; Poehlein E; You W; Robertson MM; Zimba R; Westmoreland DA; Romo ML; Kulkarni SG; Chang M; Berry A; Parcesepe AM; Maroko AR; Grov C; Nash D;
    Am J Epidemiol; 2022 Mar; 191(4):570-583. PubMed ID: 34999751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study.
    McKeigue PM; McAllister DA; Hutchinson SJ; Robertson C; Stockton D; Colhoun HM
    Lancet Respir Med; 2022 Jun; 10(6):566-572. PubMed ID: 35227416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The relationship between COVID-19 vaccination status in pregnancy and birthweight.
    Gaur P; Darwin KC; Kohn JR; Uribe KA; Shippey E; Eke AC
    Am J Obstet Gynecol MFM; 2023 Sep; 5(9):101057. PubMed ID: 37330010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High COVID-19 vaccine uptake following initial hesitancy among people in Australia who inject drugs.
    Price O; Dietze P; Maher L; Dore GJ; Sutherland R; Salom C; Bruno R; Crawford S; Degenhardt L; Larney S; Peacock A
    Vaccine; 2024 Apr; 42(11):2877-2885. PubMed ID: 38519346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records.
    Niesen MJM; Pawlowski C; O'Horo JC; Challener DW; Silvert E; Donadio G; Lenehan PJ; Virk A; Swift MD; Speicher LL; Gordon JE; Geyer HL; Halamka JD; Venkatakrishnan AJ; Soundararajan V; Badley AD
    JAMA Netw Open; 2022 Apr; 5(4):e227038. PubMed ID: 35420661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Effect of COVID-19 Vaccination on Outpatient Antibiotic Prescribing in Older Adults: A Self-Controlled Risk-Interval Study.
    Jorgensen SCJ; Brown K; Clarke AE; Schwartz KL; Maxwell C; Daneman N; Kwong JC; MacFadden DR
    Clin Infect Dis; 2024 Aug; 79(2):375-381. PubMed ID: 38700036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
    Vinh DC; Gouin JP; Cruz-Santiago D; Canac-Marquis M; Bernier S; Bobeuf F; Sengupta A; Brassard JP; Guerra A; Dziarmaga R; Perez A; Sun Y; Li Y; Roussel L; Langelier MJ; Ke D; Arnold C; Whelan M; Pelchat M; Langlois MA; Zhang X; Mazer BD;
    Lancet Healthy Longev; 2022 Mar; 3(3):e166-e175. PubMed ID: 35224524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
    Voysey M; Costa Clemens SA; Madhi SA; Weckx LY; Folegatti PM; Aley PK; Angus B; Baillie VL; Barnabas SL; Bhorat QE; Bibi S; Briner C; Cicconi P; Clutterbuck EA; Collins AM; Cutland CL; Darton TC; Dheda K; Dold C; Duncan CJA; Emary KRW; Ewer KJ; Flaxman A; Fairlie L; Faust SN; Feng S; Ferreira DM; Finn A; Galiza E; Goodman AL; Green CM; Green CA; Greenland M; Hill C; Hill HC; Hirsch I; Izu A; Jenkin D; Joe CCD; Kerridge S; Koen A; Kwatra G; Lazarus R; Libri V; Lillie PJ; Marchevsky NG; Marshall RP; Mendes AVA; Milan EP; Minassian AM; McGregor A; Mujadidi YF; Nana A; Padayachee SD; Phillips DJ; Pittella A; Plested E; Pollock KM; Ramasamy MN; Ritchie AJ; Robinson H; Schwarzbold AV; Smith A; Song R; Snape MD; Sprinz E; Sutherland RK; Thomson EC; Török ME; Toshner M; Turner DPJ; Vekemans J; Villafana TL; White T; Williams CJ; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ;
    Lancet; 2021 Mar; 397(10277):881-891. PubMed ID: 33617777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales.
    Bedston S; Almaghrabi F; Patterson L; Agrawal U; Woolford L; Anand SN; Joy M; Crawford A; Goudie R; Byford R; Abbasizanjani H; Smith D; Laidlaw L; Akbari A; Sullivan C; Bradley DT; Lyons RA; de Lusignan S; Hobbs FDR; Robertson C; Sheikh SA; Shi T
    Lancet Reg Health Eur; 2024 Feb; 37():100816. PubMed ID: 38162515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records.
    Horne EMF; Hulme WJ; Keogh RH; Palmer TM; Williamson EJ; Parker EPK; Green A; Walker V; Walker AJ; Curtis H; Fisher L; MacKenna B; Croker R; Hopcroft L; Park RY; Massey J; Morley J; Mehrkar A; Bacon S; Evans D; Inglesby P; Morton CE; Hickman G; Davy S; Ward T; Dillingham I; Goldacre B; Hernán MA; Sterne JAC
    BMJ; 2022 Jul; 378():e071249. PubMed ID: 35858698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
    Shrotri M; Krutikov M; Palmer T; Giddings R; Azmi B; Subbarao S; Fuller C; Irwin-Singer A; Davies D; Tut G; Lopez Bernal J; Moss P; Hayward A; Copas A; Shallcross L
    Lancet Infect Dis; 2021 Nov; 21(11):1529-1538. PubMed ID: 34174193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Seroprevalence of anti-SARS-CoV-2 IgG antibodies pre- and post-COVID-19 vaccination in staff members of Bandar Abbas Children's Hospital.
    Tariverdi M; Mohammadi H; Hassanzadeh F; Tamaddondar M
    BMC Infect Dis; 2024 Feb; 24(1):253. PubMed ID: 38395759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020-17 May 2021): a population-level observational study.
    Tessier E; Rai Y; Clarke E; Lakhani A; Tsang C; Makwana A; Heard H; Rickeard T; Lakhani S; Roy P; Edelstein M; Ramsay M; Lopez-Bernal J; White J; Andrews N; Campbell CNJ; Stowe J
    BMJ Open; 2022 Mar; 12(3):e055278. PubMed ID: 35232787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pregnancy Outcomes in Patients After Completion of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Compared With Unvaccinated Patients.
    Morgan JA; Biggio JR; Martin JK; Mussarat N; Elmayan A; Chawla HK; Kandalaft S; Magalski GR; Puri P; Williams FB
    Obstet Gynecol; 2023 Mar; 141(3):555-562. PubMed ID: 36735413
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of post-vaccination immunoglobulin G antibodies and T-cell immune response after inoculation with different types and doses of SARS-CoV-2 vaccines: A retrospective cohort study.
    Al-Rifai RH; Alhosani F; Abuyadek R; Atef S; Donnelly JG; Leinberger-Jabari A; Ahmed LA; Altrabulsi B; Alatoom A; Alsuwaidi AR; AbdelWareth L
    Front Med (Lausanne); 2022; 9():1092646. PubMed ID: 36703898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa.
    Osuagwu UL; Mashige KP; Ovenseri-Ogbomo G; Envuladu EA; Abu EK; Miner CA; Timothy CG; Ekpenyong BN; Langsi R; Amiebenomo OM; Oloruntoba R; Goson PC; Charwe DD; Ishaya T; Agho KE
    BMC Public Health; 2023 Jan; 23(1):38. PubMed ID: 36609264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.